SCN8A and Parkinson disease: This finding further broadened the implication for phosphorylation of Nav1.6 in the context of neural plasticity and could aid in the development of novel therapies for brain disorders (Alzheimer’s, Parkinson’s, Huntington’s, etc.)associated with either upregulation of GSK3β or Nav1.6 activity [115,116,117,118].